Michael J. Welsh - Net Worth and Insider Trading

Michael J. Welsh Net Worth

The estimated net worth of Michael J. Welsh is at least $774 dollars as of 2024-05-05. Michael J. Welsh is the Director of Cancer Genetics Inc and owns about 168 shares of Cancer Genetics Inc (CGIX) stock worth over $774. Details can be seen in Michael J. Welsh's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael J. Welsh has not made any transactions after 2016-03-16 and currently still holds the listed stock(s).

Transaction Summary of Michael J. Welsh

To

Michael J. Welsh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael J. Welsh owns 2 companies in total, including Cancer Genetics Inc (CGIX) , and Vyant Bio Inc (VYNT) .

Click here to see the complete history of Michael J. Welsh’s form 4 insider trades.

Insider Ownership Summary of Michael J. Welsh

Ticker Comapny Transaction Date Type of Owner
CGIX Cancer Genetics Inc 2017-09-28 director
VYNT Vyant Bio Inc 2014-05-22 director

Michael J. Welsh Latest Holdings Summary

Michael J. Welsh currently owns a total of 1 stock. Michael J. Welsh owns 168 shares of Cancer Genetics Inc (CGIX) as of March 16, 2016, with a value of $774.

Latest Holdings of Michael J. Welsh

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CGIX Cancer Genetics Inc 2016-03-16 168 4.61 774

Holding Weightings of Michael J. Welsh


Michael J. Welsh Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael J. Welsh has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the acquisition of 1 shares on March 16, 2016, which cost Michael J. Welsh around $97.

Insider Trading History of Michael J. Welsh

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael J. Welsh Trading Performance

GuruFocus tracks the stock performance after each of Michael J. Welsh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael J. Welsh is -14.46%. GuruFocus also compares Michael J. Welsh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael J. Welsh within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael J. Welsh's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael J. Welsh

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.16
Relative Return to S&P 500(%) 8.52

Michael J. Welsh Ownership Network

Ownership Network List of Michael J. Welsh

No Data

Ownership Network Relation of Michael J. Welsh


Michael J. Welsh Owned Company Details

What does Cancer Genetics Inc do?

Who are the key executives at Cancer Genetics Inc?

Michael J. Welsh is the director of Cancer Genetics Inc. Other key executives at Cancer Genetics Inc include President & Discovery Services Ralf Brandt , Chief Financial Officer Michael Glenn Miles , and Chief Executive Officer John A Roberts .

Cancer Genetics Inc (CGIX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cancer Genetics Inc (CGIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cancer Genetics Inc (CGIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cancer Genetics Inc (CGIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cancer Genetics Inc Insider Transactions

No Available Data

Michael J. Welsh Mailing Address

Above is the net worth, insider trading, and ownership report for Michael J. Welsh. You might contact Michael J. Welsh via mailing address: Univ. Of Iowa Carver College Of Medicine, Dept. Of Internal Medicine, 500 Emrb, Iowa City Ia 52242.

Discussions on Michael J. Welsh

No discussions yet.